MediciNova, Inc. (MNOV)Healthcare | Biotechnology | La Jolla, United States | NasdaqGM
1.46 USD
+0.02
(1.389%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.46 Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 7:39 p.m. EDT
MediciNova presents a classic 'high risk, low conviction' scenario: while analyst consensus paints a picture of massive upside (Target Mean $9.00 vs Price $1.46), the fundamentals tell a story of dilution and burning cash without a clear path to profitability. The approval for a 147M share increase is a fundamental negative that threatens to crush per-share value, making the 'Moderate Buy' analyst ratings potentially disconnected from the shareholder dilution reality. The lack of dividend history, combined with a negative earnings-per-share trajectory and negligible options liquidity, creates a trap where the only 'upside' relies entirely on a binary biotech catalyst that has yet to materialize. Until the dilution is priced in and cash flow stabilizes, this remains a speculative hold rather than a buy. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.057896 |
| AutoETS | 0.218496 |
| MSTL | 0.220507 |
| AutoTheta | 0.237400 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 58% |
| H-stat | 2.01 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.055 |
| Excess Kurtosis | 0.83 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.508 |
| Revenue per Share | 0.008 |
| Market Cap | 71,863,024 |
| Forward P/E | -3.52 |
| Beta | 0.61 |
| Website | https://medicinova.com |
As of April 18, 2026, 7:39 p.m. EDT: Speculative positioning is extremely muted with negligible volume and open interest in both calls and puts. Calls show only 6 contracts total volume for April expiration and 21 Open Interest, with strikes significantly above current price (OTM at 2.5 and 5.0). Put volume is equally sparse (1-2 contracts) with zero Open Interest. The implied volatility is exceptionally low (1.29% - 14.0%), suggesting the options market expects minimal price movement or lacks liquidity entirely. There is no directional signal from options flow to support either a bullish or bearish thesis.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.0068027377 |
| Address1 | 4,275 Executive Square |
| Address2 | Suite 300 |
| All Time High | 16.12 |
| All Time Low | 1.12 |
| Ask | 1.84 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 29,390 |
| Average Daily Volume3 Month | 63,653 |
| Average Volume | 63,653 |
| Average Volume10Days | 29,390 |
| Beta | 0.606 |
| Bid | 1.05 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 0.845 |
| City | La Jolla |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.46 |
| Current Ratio | 8.161 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.4665 |
| Day Low | 1.42 |
| Debt To Equity | 0.508 |
| Display Name | MediciNova |
| Earnings Timestamp | 1,771,594,200 |
| Earnings Timestamp End | 1,778,675,400 |
| Earnings Timestamp Start | 1,778,675,400 |
| Ebitda | -13,262,903 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.112 |
| Enterprise To Revenue | 100.738 |
| Enterprise Value | 41,268,004 |
| Eps Current Year | -0.3 |
| Eps Forward | -0.415 |
| Eps Trailing Twelve Months | -0.24 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 858 404 0048 |
| Fifty Day Average | 1.4576 |
| Fifty Day Average Change | 0.0024000406 |
| Fifty Day Average Change Percent | 0.0016465702 |
| Fifty Two Week Change Percent | -0.6802738 |
| Fifty Two Week High | 1.96 |
| Fifty Two Week High Change | -0.5 |
| Fifty Two Week High Change Percent | -0.25510204 |
| Fifty Two Week Low | 1.17 |
| Fifty Two Week Low Change | 0.29000008 |
| Fifty Two Week Low Change Percent | 0.24786332 |
| Fifty Two Week Range | 1.17 - 1.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,165,588,200,000 |
| Float Shares | 42,255,947 |
| Forward Eps | -0.415 |
| Forward P E | -3.5180724 |
| Free Cashflow | -6,088,045 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 6 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0758 |
| Gross Profits | 31,051 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02875 |
| Held Percent Institutions | 0.21916 |
| Implied Shares Outstanding | 49,221,247 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. |
| Long Name | MediciNova, Inc. |
| Market | us_market |
| Market Cap | 71,863,024 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_9262264 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -11,997,957 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 71,370,806 |
| Number Of Analyst Opinions | 4 |
| Open | 1.44 |
| Operating Cashflow | -9,810,061 |
| Operating Margins | -20.37974 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 858 373 1500 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.46 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 1.44 |
| Price Eps Current Year | -4.866667 |
| Price Hint | 4 |
| Price To Book | 1.7278106 |
| Price To Sales Trailing12 Months | 175.42242 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.112 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.02 |
| Regular Market Change Percent | 1.38889 |
| Regular Market Day High | 1.4665 |
| Regular Market Day Low | 1.42 |
| Regular Market Day Range | 1.42 - 1.4665 |
| Regular Market Open | 1.44 |
| Regular Market Previous Close | 1.44 |
| Regular Market Price | 1.46 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 17,778 |
| Return On Assets | -0.16362 |
| Return On Equity | -0.25503 |
| Revenue Per Share | 0.008 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 49,221,246 |
| Shares Percent Shares Out | 0.0041 |
| Shares Short | 201,034 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 193,563 |
| Short Name | MediciNova, Inc. |
| Short Percent Of Float | 0.0047999998 |
| Short Ratio | 2.78 |
| Source Interval | 15 |
| State | CA |
| Symbol | MNOV |
| Target High Price | 11.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 9.0 |
| Target Median Price | 9.5 |
| Total Cash | 30,806,476 |
| Total Cash Per Share | 0.626 |
| Total Debt | 211,460 |
| Total Revenue | 409,657 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.24 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.3968 |
| Two Hundred Day Average Change | 0.0632 |
| Two Hundred Day Average Change Percent | 0.045246273 |
| Type Disp | Equity |
| Volume | 17,778 |
| Website | https://medicinova.com |
| Zip | 92,037 |